1. Home
  2. DLHC vs VRCA Comparison

DLHC vs VRCA Comparison

Compare DLHC & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DLH Holdings Corp.

DLHC

DLH Holdings Corp.

HOLD

Current Price

$5.71

Market Cap

83.8M

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.47

Market Cap

87.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLHC
VRCA
Founded
1969
2013
Country
United States
United States
Employees
2300
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.8M
87.5M
IPO Year
2012
2018

Fundamental Metrics

Financial Performance
Metric
DLHC
VRCA
Price
$5.71
$6.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
6.4K
75.6K
Earning Date
05-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,923,000.00
$35,577,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.05
$94.44
P/E Ratio
N/A
N/A
Revenue Growth
2.57
370.22
52 Week Low
$3.41
$0.39
52 Week High
$8.09
$9.82

Technical Indicators

Market Signals
Indicator
DLHC
VRCA
Relative Strength Index (RSI) 49.36 61.74
Support Level $5.55 $5.16
Resistance Level $6.05 $8.08
Average True Range (ATR) 0.26 0.43
MACD 0.01 0.12
Stochastic Oscillator 49.58 84.16

Price Performance

Historical Comparison
DLHC
VRCA

About DLHC DLH Holdings Corp.

DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.

Share on Social Networks: